These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1626937)

  • 1. [The study on intravesical instillation of THP in the treatment of in-situ and superficial bladder cancers].
    Aota Y; Okamoto N; Morikawa S; Yoshida K
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1015-8. PubMed ID: 1626937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A randomized study on intravesical pirarubicin (THP) chemoprophylaxis of recurrence after transurethral resection of superficial bladder cancer].
    Miki T; Nonomura N; Kojima Y; Okuyama A; Nakano E; Kiyohara H; Fujioka H; Koide T; Wakatsuki A; Kuroda H; Sugao H; Seguti T; Takeyama M; Yamaguchi S
    Hinyokika Kiyo; 1997 Dec; 43(12):907-12. PubMed ID: 9488944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Postoperative intravesical instillation of THP for superficial bladder tumor: clinical results of prophylactic effects on the recurrence. Fukushima THP Research Group].
    Aikawa K; Irisawa C; Muraki O; Yamaguchi O; Shiraiwa Y; Noguchi M; Koguchi M; Yokoyama J; Ito K; Kumakawa K
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):509-13. PubMed ID: 1558401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Short-duration bladder instillation therapy with pirarubicin for superficial bladder tumor based on pharmacodynamic study].
    Nakagawa S; Kojima M; Takada H; Sugimoto K; Mikami K; Watanabe H
    Gan To Kagaku Ryoho; 1992 Sep; 19(11):1873-7. PubMed ID: 1519929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Appropriate intravesical retention time of pirarubicin concentration based on its level in tumor tissue, anti-tumor effect and side effect in intravesical instillation therapy for bladder tumor].
    Kobayashi M; Sugaya Y; Yuzawa M; Ochi M; Morita T; Kobayashi Y; Tokue A; Hara Y
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1771-4. PubMed ID: 9757205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravesial instillation of recombination interferon-alpha and pirarubicin in the prophylaxis of local recurrence after resection of the superficial bladder cancer].
    Deng JH; Bai JL; Zhang SS; Ma PC; Wan JH
    Ai Zheng; 2004 Jul; 23(7):839-41. PubMed ID: 15248924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A randomized study of pirarubicin (THP) versus adriamycin (ADM) for intravesical instillation therapy against superficial bladder cancer].
    Kawamura J; Tochigi H; Obata K; Ueda K; Otaguro K; Kuriyama M; Shinoda M; Naruse K; Murase T; Hasegawa Y
    Hinyokika Kiyo; 1992 Mar; 38(3):379-85. PubMed ID: 1523998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short-term intravesical instillation of pirarubicin (THP) in prophylactic treatment after transurethral resection of superficial bladder tumor].
    Kuroda K; Ishii N; Fukasawa K; Shirai M; Tajima M; Matsushima M; Miura K; Takanami M; Matsuhashi M; Kuwabara T; Matsumoto H; Sugita M
    Hinyokika Kiyo; 1998 Aug; 44(8):547-52. PubMed ID: 9783189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravesical instillation on performance of uCYT+ test.
    Lodde M; Mian C; Negri G; Vittadello F; Comploj E; Palermo S; Staffler A; Brössner C; Pycha A
    Urology; 2004 May; 63(5):878-81. PubMed ID: 15134970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postoperative prophylactic intravesical instillation of tetrahydropyranyl-adriamycin (THP) for superficial bladder cancer].
    Kanayama H; Yokota K; Kurokawa Y; Kagawa S; Yokozeki H; Inai T; Ogawa I; Akazawa S; Hashimoto H; Mizuta K
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):651-5. PubMed ID: 10234296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of retention time of intravesical instillation therapy with pirarubicin (THP)].
    Sugano O; Shoji N; Hatakeyama T; Kato H
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1169-74. PubMed ID: 8751805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A course of pirarubicin vesical irrigation at thirty mg effectively prevents post-TUR recurrence of superficial bladder cancer].
    Kawamura S; Fujioka T; Kubo T; Yoshida I; Takata K
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):465-70. PubMed ID: 8678499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravesical instillation of pirarubicin for a patient with bladder cancer and chronic renal failure: a case report].
    Tanomogi H; Masuda T; Yamamoto Y; Arima K; Matsuoka Y
    Hinyokika Kiyo; 1995 May; 41(5):391-3. PubMed ID: 7598041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A randomized study of prophylactic intravesical instillation of pirarubicin (THP) prior to transurethral resection of superficial bladder cancer].
    Hashimura T; Shirahase T; Inoue T; Yamasaki T; Terada N; Ogura K; Arai Y; Hida S; Ueda T
    Hinyokika Kiyo; 2005 Jul; 51(7):439-42. PubMed ID: 16119805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial.
    Ito A; Shintaku I; Satoh M; Ioritani N; Aizawa M; Tochigi T; Kawamura S; Aoki H; Numata I; Takeda A; Namiki S; Namima T; Ikeda Y; Kambe K; Kyan A; Ueno S; Orikasa K; Katoh S; Adachi H; Tokuyama S; Ishidoya S; Yamaguchi T; Arai Y
    J Clin Oncol; 2013 Apr; 31(11):1422-7. PubMed ID: 23460707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 mutation predicts intravesical adriamycin instillation failure in superficial transitional cell carcinoma of bladder.
    Shiraishi K; Eguchi S; Mohri J; Kamiryo Y
    Anticancer Res; 2003; 23(4):3475-8. PubMed ID: 12926093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prophylactic effect of pirarubicin (THP) on postoperative recurrence of superficial bladder cancer in terms of intravesical retention time].
    Nonomura N; Nishimura K; Okuyama A; Miki T; Kishimoto T; Kiyohara H; Wakatsuki A; Fujioka H; Kuroda H; Nakano E; Takeyama M; Koide T; Yamaguchi S
    Hinyokika Kiyo; 2001 May; 47(5):315-9. PubMed ID: 11433751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intravesical chemotherapy of (2''R)-4'-O-tetrahydropyranyladriamycin in bladder tumor].
    Masuda H; Hirose J; Suzuki K; Tajima A; Aso Y
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2411-4. PubMed ID: 3729494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized study of single instillation of epirubicin for superficial bladder carcinoma: long-term clinical outcomes.
    Liu B; Wang Z; Chen B; Yu J; Zhang P; Ding Q; Zhang Y
    Cancer Invest; 2006 Mar; 24(2):160-3. PubMed ID: 16537185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism of intravesical instillation of pirarubicin for preventing recurrence of non-muscle invasive bladder cancer].
    Li Q; Xu T; Wang XF
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):904-7. PubMed ID: 20193328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.